Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28883016)

Published in Dis Model Mech on September 01, 2017

Authors

Victorio M Pozo Devoto1,2, Tomas L Falzone3,4

Author Affiliations

1: Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina.
2: International Clinical Research Center (ICRC), St. Anne's University Hospital, CZ-65691, Brno, Czech Republic.
3: Instituto de Biología Celular y Neurociencias, IBCN (UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Buenos Aires, CP1121, Argentina tfalzone@fmed.uba.ar.
4: Instituto de Biología y Medicina Experimental, IBYME-CONICET, Vuelta de Obligado 2490, Buenos Aires, CP1428, Argentina.

Articles cited by this

(truncated to the top 100)

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol (2008) 17.81

Genome engineering using the CRISPR-Cas9 system. Nat Protoc (2013) 15.98

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92

Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J (2008) 12.89

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol (2004) 9.62

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science (2004) 8.71

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A (1998) 8.41

Epidemiology of Parkinson's disease. Lancet Neurol (2006) 8.13

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet (2000) 7.83

Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science (2006) 7.72

During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol (2011) 7.40

A more efficient method to generate integration-free human iPS cells. Nat Methods (2011) 7.39

Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res (2004) 7.06

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron (2000) 6.92

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A (2009) 6.87

Modification of Parkinsonism--chronic treatment with L-dopa. N Engl J Med (1969) 6.16

PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell (2011) 5.98

Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A (2006) 5.78

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science (2010) 5.42

Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc Natl Acad Sci U S A (2010) 5.17

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron (1995) 4.78

Mitochondrial fusion intermediates revealed in vitro. Science (2004) 4.52

In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A (2011) 4.38

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci (1988) 4.36

Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell (1998) 4.35

Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J Cell Biol (2006) 4.28

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature (2010) 4.07

A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem (2000) 3.97

Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem (2004) 3.87

Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem (2008) 3.86

Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons. J Cell Biol (1995) 3.74

Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol (2006) 3.72

The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron (2005) 3.71

Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci (2009) 3.68

α-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol (2010) 3.67

Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila. Genetics (1996) 3.56

Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron (2002) 3.52

Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron (2010) 3.49

Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron (2009) 3.49

Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J Cell Biol (2010) 3.37

Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy (2005) 3.27

Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest (2009) 3.17

Translational principles of deep brain stimulation. Nat Rev Neurosci (2007) 3.10

Mitochondria: the next (neurode)generation. Neuron (2011) 3.06

Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci U S A (2008) 3.04

Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem (2008) 2.86

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci (2006) 2.85

The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci (2013) 2.78

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci (1998) 2.78

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology (2007) 2.72

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci (1985) 2.70

Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci (2012) 2.68

Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J Neurosci (2012) 2.64

Atypical Rho GTPases have roles in mitochondrial homeostasis and apoptosis. J Biol Chem (2002) 2.56

Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci (2010) 2.55

The hemifusion intermediate and its conversion to complete fusion: regulation by membrane composition. Biophys J (1995) 2.55

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem (2008) 2.53

Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell (2009) 2.49

The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ (2012) 2.45

Moving mitochondria: establishing distribution of an essential organelle. Traffic (2007) 2.44

Yeast Miro GTPase, Gem1p, regulates mitochondrial morphology via a novel pathway. J Cell Biol (2004) 2.42

Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol (2011) 2.39

Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A (2010) 2.34

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One (2008) 2.33

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem (1998) 2.32

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A (1999) 2.30

Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell (2013) 2.22

What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev (2011) 2.21

Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain (2012) 2.18

Lewy bodies. Proc Natl Acad Sci U S A (2006) 2.15

Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J (2010) 2.12

Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol (2010) 2.12

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A (2015) 2.08

The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord (2014) 2.02

Mitochondrial dynamics in neurodegeneration. Trends Cell Biol (2012) 1.99

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med (2012) 1.99

Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci (2011) 1.98

Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96

Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci (2013) 1.88

Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J Biol Chem (2000) 1.83

Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol (2010) 1.81

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta Neuropathol (2013) 1.75

Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med (2012) 1.75

Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J Biol Chem (2009) 1.71

Ageing as a risk factor for disease. Curr Biol (2012) 1.71

Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein. Biochemistry (2004) 1.71

Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. Mov Disord (2013) 1.64

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord (2011) 1.62

Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS One (2010) 1.62

Understanding the molecular causes of Parkinson's disease. Trends Mol Med (2006) 1.62

TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. Neuron (2013) 1.60

Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med (2015) 1.59

Mitochondria as a central sensor for axonal degenerative stimuli. Trends Neurosci (2012) 1.58

Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport. J Neurosci (2009) 1.57

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet (2012) 1.56

alpha-Synuclein produces a long-lasting increase in neurotransmitter release. EMBO J (2004) 1.54

Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat Rev Neurol (2014) 1.52

Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J Mol Biol (2002) 1.52

Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy. Biochemistry (2010) 1.50